These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A radioimmunoassay method for 1-beta-D-arabinofuranosyluracil using antibodies directed against 1-beta-D-arabinofuranosylcytosine. Okabayashi T; Mihara S; Moffatt JG Cancer Res; 1977 Feb; 37(2):625-8. PubMed ID: 12864 [TBL] [Abstract][Full Text] [Related]
3. A radioimmunoassay for 1-beta-D-arabinofuranosylcytosine. Okabayashi T; Mihara S; Repke DB; Moffatt JG Cancer Res; 1977 Feb; 37(2):619-24. PubMed ID: 832282 [TBL] [Abstract][Full Text] [Related]
4. A radioimmunoassay for 1-beta-D-arabinofuranosyluracil with reference to cross-reactivity of 1-beta-D-arabinofuranosylcytosine with an antibody. Okabayashi T; Mihara S; Repke DB; Moffatt JG Cancer Res; 1977 Sep; 37(9):3132-5. PubMed ID: 18280 [TBL] [Abstract][Full Text] [Related]
5. Antitumor activities of newly synthesized N4-acyl-1-beta-D-arabinofuranosylcytosine. Aoshima M; Tsukagoshi S; Sakurai Y; Oh-ishi J; Ishida T Cancer Res; 1976 Aug; 36(8):2726-32. PubMed ID: 1277182 [TBL] [Abstract][Full Text] [Related]
6. Close correlation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate, an intracellular active metabolite, to the therapeutic efficacy of N(4)-behenoyl-1-beta-D-arabinofuranosylcytosine therapy for acute myelogenous leukemia. Yamauchi T; Kawai Y; Goto N; Kishi S; Imamura S; Yoshida A; Urasaki Y; Fukushima T; Iwasaki H; Tsutani H; Masada M; Ueda T Jpn J Cancer Res; 2001 Sep; 92(9):975-82. PubMed ID: 11572766 [TBL] [Abstract][Full Text] [Related]
7. Cellular pharmacology of a liposomal preparation of N4-hexadecyl-1-beta-D-arabinofuranosylcytosine, a lipophilic derivative of 1-beta-D-arabinofuranosylcytosine. Horber DH; Schott H; Schwendener RA Br J Cancer; 1995 May; 71(5):957-62. PubMed ID: 7734320 [TBL] [Abstract][Full Text] [Related]
8. Relationship of 1-beta-D-arabinofuranosylcytosine in plasma to 1-beta-D-arabinofuranosylcytosine 5'-triphosphate levels in leukemic cells during treatment with high-dose 1-beta-D-arabinofuranosylcytosine. Liliemark JO; Plunkett W; Dixon DO Cancer Res; 1985 Nov; 45(11 Pt 2):5952-7. PubMed ID: 4053067 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine-5'-diphosphate-prednisolone and -cortisol. Hong CI; Nechaev A; West CR Biochem Biophys Res Commun; 1980 Jun; 94(4):1169-76. PubMed ID: 6249301 [No Abstract] [Full Text] [Related]
10. Synthesis and structure-activity studies in vivo of liposomal phospholipid-N4-palmitoyl- and N4-hexadecyl-1-beta-D-arabinofuranosylcytosine conjugates. Schott H; Schwendener RA Anticancer Drug Des; 1996 Sep; 11(6):451-62. PubMed ID: 8836110 [TBL] [Abstract][Full Text] [Related]
11. [The effect of N4-behenoyl-1-beta-D-arabinofuranosylcytosine on human erythrocytes]. Moriguchi T; Kakita T; Nishimura T; Kubo A; Ueda T; Nakamura T; Sasada M; Uchino H Rinsho Ketsueki; 1987 Sep; 28(9):1568-75. PubMed ID: 3437519 [No Abstract] [Full Text] [Related]
12. Formation of 1-beta-D-arabinofuranosylcytosine diphosphate choline in neoplastic and normal cells. Lauzon GJ; Paterson AR; Belch AW Cancer Res; 1978 Jun; 38(6):1730-3. PubMed ID: 274175 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the conjugate between N4-(4-carboxybutyryl)-1-beta-D-arabinofuranosylcytosine and chitosan as a macromolecular prodrug of 1-beta-D-arabinofuranosylcytosine. Ichikawa H; Onishi H; Takahata T; Machida Y; Nagai T Drug Des Discov; 1993; 10(4):343-53. PubMed ID: 8148473 [TBL] [Abstract][Full Text] [Related]
14. Pharmacology of 5'-esters of 1-beta-D-arabinofuranosylcytosine. Ho DH; Neil GL Cancer Res; 1977 Jun; 37(6):1640-3. PubMed ID: 870178 [TBL] [Abstract][Full Text] [Related]
15. 2'-O-nitro-1-beta-D-arabinofuranosylcytosine. A new derivative of 1-beta-D-arabinofuranosylcytosine that resists enzymatic deamination and has antileukemic activity. Chwang TL; Fridland A; Avery TL J Med Chem; 1983 Feb; 26(2):280-3. PubMed ID: 6827546 [TBL] [Abstract][Full Text] [Related]
16. Production of N4-succinyl-1-beta-D-arabinofuranosylcytosine, a novel metabolite of N4-behenoyl-1-beta-D-arabinofuranosylcytosine, in mice and its biological significance. Oh-ishi J; Kataoka T; Tsukagoshi S; Sakurai Y; Shibukawa M; Kobayashi H Cancer Res; 1981 Jun; 41(6):2501-6. PubMed ID: 7237444 [TBL] [Abstract][Full Text] [Related]
17. N4-Behenoyl-1-beta-D-arabinofuranosylcytosine as a potential new antitumor agent. Aoshima M; Tsukagoshi S; Sakurai Y; Oh-ishi JI; Ishida T Cancer Res; 1977 Aug; 37(8 Pt 1):2481-6. PubMed ID: 872077 [TBL] [Abstract][Full Text] [Related]
18. Enzyme catalyzation of the deacylation of N4-acyl derivatives of 1-beta-D-arabinofuranosylcytosine in the mouse liver microsome. Tsuruo T; Hori K; Iida H; Tsukagoshi S; Sakurai Y Cancer Res; 1982 Jun; 42(6):2250-4. PubMed ID: 7074607 [TBL] [Abstract][Full Text] [Related]
19. Formulation, stability, and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugate of thioether phospholipid. Hong CI; Bernacki RJ; Hui SW; Rustum Y; West CR Cancer Res; 1990 Jul; 50(14):4401-6. PubMed ID: 2364392 [TBL] [Abstract][Full Text] [Related]
20. Enhancement by tetrahydrouridine of 1-beta-D-arabinofuranosylcytosine (cytarabine) oral activity in L1210 leukemic mice. Neil GL; Moxley TE; Manak RC Cancer Res; 1970 Aug; 30(8):2166-72. PubMed ID: 4990003 [No Abstract] [Full Text] [Related] [Next] [New Search]